Peigen He
Hubei University of Medicine(CN)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Spondyloarthritis Studies and Treatments, T-cell and B-cell Immunology, Psoriasis: Treatment and Pathogenesis
Most-Cited Works
- → A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis(2011)166 cited
- → Multicenter, randomized, double‐blind, controlled trial of treatment of active rheumatoid arthritis with T‐614 compared with methotrexate(2009)83 cited
- → The relationship between disease activity measured by the BASDAI and psychological status, stressful life events, and sleep quality in ankylosing spondylitis(2014)47 cited
- Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.(2003)
- → Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids(2018)26 cited
- → Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients(2009)21 cited
- → PHACTR1 gene polymorphism with the risk of coronary artery disease in Chinese Han population(2019)18 cited
- → Immunophenotyping of lymphocyte T and B in the peripheral blood of systemic lupus erythematosus(2001)6 cited
- → Expression of costimulatory molecules B7/CD28 in systemic lupus erythematosus(2004)4 cited
- [A study of the hereditary susceptibility of HLA-DQA1 to essential hypertension, athrothrombotic brain infarction and lacunar stroke].(2001)